Oscar Health (OSCR) Stock: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$32.54
0.65 (2.04%)
â˛
5d:
-4.32%
30d:
+1.28%
90d:
+5.75%
WAIT
LOW Confidence
Analysis Updated: Oct 19, 2026 12:00 AM ET
Earnings: Nov 05, 2026
15d
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OSCR is fairly priced but lacks strong directional signals. At -0.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OSCR is fairly priced but lacks strong directional signals. At -0.5% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$51.12
Based on 9.2% avg growth
INTRINSIC VALUE TODAY
$31.74
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $32.54, which is considered fair relative to its 30-day fair value range of $30.46 to $33.42. The stock's valuation (Forward PE: 14.7) is in line with its historical norms (14.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This pessimistic expectation contrasts with the company's recent 125.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OSCR is in a uptrend. The price is currently testing key support at $31.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OSCR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.40 (+11.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSCR is in a uptrend. The price is currently testing key support at $31.65. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: OSCR scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $36.40 (+11.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$30.46 -
$33.42
Company Quality Score
48/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.6%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($36.40)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$30.46 -
$33.42
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$31.65
Resistance Level
$35.01
Current Trend
Uptrend
Technical data as of
Oct 19, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.65
Wall Street Target
$36.40
(+11.9%)
Revenue Growth (YoY)
70.4%
Earnings Growth (YoY)
125.6%
Profit Margin
3.6%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
14.7 vs 14.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$32.38
(-1%)
2-Year Target
$32.22
(-1%)
3-Year Target
$32.05
(-2%)
3-Yr Target (if PE normalizes)
(PE: 15â15)
$32.60
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 19.9, Growth: 14.3%)
$65.80
(+102%)
Base:
(SPY PE: 14.7, Growth: 14.3%)
$48.54
(+49%)
Bear:
(PE: 12.5, Growth: 14.3%)
$41.26
(+27%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (25x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 24.72 | Current EPS (TTM): $1.29
Bull Case
$60.39
(+86%)
Analyst growth 72.2%, PE expands to 27.2
Base Case
$54.90
(+69%)
Market implied 72.2%, PE stable at 24.7
Bear Case
$21.69
(-33%)
Severe decline -20.0%, PE contracts to 21.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.7 to 14.9
Stabilization Target:
$33.09
(+1.7%)
PE Expansion Potential:
+1.7%
Share & Embed Analysis
Last updated: October 20, 2026 7:09 AM ET
Data refreshes hourly during market hours. Next update: 8:09 AM
Data refreshes hourly during market hours. Next update: 8:09 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
27 analysts |
$115 | 41 HOLD |
|
UNH
UnitedHealth Group IncorâĻ |
STRONG BUY
26 analysts |
$477 | 39 SELL |
|
HUM
Humana Inc |
BUY
26 analysts |
$465 | 51 HOLD |
|
CI
Cigna Corp |
STRONG BUY
24 analysts |
$342 | 34 SELL |
|
ELV
Elevance Health Inc |
BUY
22 analysts |
$452 | 36 SELL |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
